On June 20, 2024, Microbot Medical Inc. closed the transaction. The transaction included participation from three investors. The company paid $164,500 as sales commissions in the transaction.

The placement agent received an aggregate cash fee equal to 7.0% of the gross proceeds, a management fee equal to 1.0% of the gross proceeds.